Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 16, 2013
Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers?Linda de Munck, Sabine Siesling, Joost Bart, et al.
Infectious Disease Reports|December 27, 2024
Delayed Diagnosis of Disseminated Invasive Aspergillosis with Purulent Myocarditis in an Immunocompromised HostMark Londema, Maarten W N Nijsten, Joost Bart, et al.
Annals of Surgical Oncology|July 18, 2009
Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directionsRick G Pleijhuis, Maurits Graafland, Jakob de Vries, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 22, 2011
Expression of the stem cell marker ALDH1 in BRCA1 related breast cancerMarise R Heerma van Voss, Petra van der Groep, Joost Bart, et al.
Histopathology|September 16, 2010
Methylation profiles of hereditary and sporadic ovarian cancerGuus M Bol, Karijn P M Suijkerbuijk, Joost Bart, et al.
Gynecologic Oncology Reports|December 25, 2018
Borderline tumours of the ovary: Common practice in the NetherlandsKoen De Decker, Henk G Ter Brugge, Joost Bart, et al.
Annals of Neurology|January 26, 2005
Blood-brain barrier dysfunction in parkinsonian midbrain in vivoRudie Kortekaas, Klaus L Leenders, Joost C H van Oostrom, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2026
FIGO 2021 depth of invasion measurement and missed lymph node involvement in microinvasive vulvar squamous cell carcinoma: Is the gain worth the cost?Willemijn L van der Kolk, Kim Landsbergen, Ate G J van der Zee, et al.
Cancers|May 11, 2024
BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data StudyLieke Lanjouw, Joost Bart, Marian J E Mourits, et al.
Pageof 7